Answers are grounded in this paper and cite their sources.
Demonstrates dual antimicrobial and anticoagulant action on cellulosic surfaces coated with chitosan sulfate-encapsulated silver nanoparticles, indicating promise for blood-contact biomaterials.
The rational design of silver nanoparticles encapsulated in an anticoagulant, hemocompatible polysaccharide, 6-O-chitosan sulfate, is presented. Three different approaches are described for the immobilization of these core shell particles on cellulosic surfaces. The mass of the immobilized particles is quantified using a quartz crystal microbalance with dissipation (QCM-D). The antimicrobial activity of the surfaces towards E. coli MG 1655 [R1-16] is investigated by live/dead assays using fluorescence staining. All surfaces treated with the designed nanoparticles exhibit excellent antimicrobial activity towards E. coli MG 1655 [R1-16]. Anticoagulant properties of blood plasma on the nanoparticle treated surfaces have been determined using QCM-D. In comparison with the unmodified substrates, the total coagulation time as well as the thrombin formation time and fibrin clotting time of surfaces modified with nanoparticles are significantly increased.
No takes yet. Share an insight, caveat, or question.
Breitwieser et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: